DFCM
APLS

Dark Forest Capital Management’s Apellis Pharmaceuticals APLS Stock Holding History

Dark Forest Capital Management’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-31,091
Closed -$781K – 788
2025
Q4 		$781K Buy
+31,091
New +$729K 0.04% 715
2025
Q3 		– Sell
-104,725
Closed -$1.81M – 1149
2025
Q2 		$1.81M Buy
+104,725
New +$1.94M 0.07% 488
2022
Q4 		– Sell
-519
Closed -$35K – 1134
2022
Q3 		$35K Buy
+519
New +$30.7K 0.01% 555
2021
Q3 		– Sell
-89
Closed -$6K – 1249
2021
Q2 		$6K Buy
+89
New +$4.59K ﹤0.01% 673

Other funds holding APLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Dark Forest Capital Management's APLS Position: Q1 2026 in Review

Dark Forest Capital Management sold out of Apellis Pharmaceuticals (APLS) in Q1 2026, closing a stake of 31,091 shares — an estimated $781K sold.

Dark Forest Capital Management first reported a position in APLS in Q2 2021 and held it in 4 quarters. The position peaked at $1.81M in Q2 2025. 323 funds tracked by Wall St. Rank hold APLS as of Q1 2026.

  • Dark Forest Capital Management reported no remaining Apellis Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Dark Forest Capital Management sold 31,091 Apellis Pharmaceuticals shares in Q1 2026, an estimated $781K.
  • Dark Forest Capital Management first reported a position in Apellis Pharmaceuticals in Q2 2021 and held it in 4 quarters.
  • Dark Forest Capital Management's Apellis Pharmaceuticals position peaked at $1.81M in Q2 2025.
  • 323 funds tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q1 2026.

Based on Dark Forest Capital Management's 13F filing for Q1 2026, filed 15 May 2026.